Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 3/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1705800 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL169329 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL2871946 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL3078400 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL1114864 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL1076957 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL2869472 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL1395419 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL10980289 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL298912 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4297258-A | Non-yellowing paint formulations containing iodo substituted alkynyl urethanes as fungicides | ICI AMERICAS INC. (US) | 1981-10-27 | — | — | US | claimed |
| US-4104175-A | FREEZE-THAW STABLE | MODOKEMI AKTIEBOLAG (SE) | 1978-08-01 | — | — | US | claimed |
| WO-2024109552-A1 | MANUFACTURING METHOD FOR LIGHT-EMITTING DEVICE, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS | TCL科技集团股份有限公司 | 2024-05-30 | — | — | WO | disclosed |
| WO-2024051766-A1 | MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-03-14 | — | — | WO | disclosed |
| WO-2023165681-A1 | RNA LIPID NANOPARTICLES (LNPS) COMPRISING A POLYOXAZOLINE AND/OR POLYOXAZINE POLYMER | BioNTech SE (DE) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023166099-A1 | RNA LIPID NANOPARTICLES (LNPs) COMPRISING A POLYOXAZOLINE AND/OR POLYOXAZINE POLYMER | BioNTech SE (DE) | 2023-09-07 | — | — | WO | disclosed |
| US-10287531-B2 | Free-flowing, solid, high active alkyl ether sulfates | GALAXY SURFACTANTS LTD. (IN) | 2019-05-14 | — | — | US | disclosed |
| EP-3022279-B1 | FREE-FLOWING, SOLID, HIGH ACTIVE ALKYL ETHER SULFATES | GALAXY SURFACTANTS LTD (IN) | 2019-03-27 | — | — | EP | disclosed |
| US-20190021998-A1 | TOPICAL NANOEMULSION THERAPY FOR WOUNDS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2019-01-24 | — | — | US | disclosed |
| EP-3010983-B1 | ANTIMICROBIAL INKS AND SEALANTS | GROS ROBERT TIMOTHY (GB) | 2019-01-16 | — | — | EP | disclosed |
| CN-109134530-A | A kind of pair of hydrophobic based surfactants and preparation method thereof | 浙江科峰有机硅有限公司 | 2019-01-04 | — | — | CN | disclosed |
| WO-2014202941-A1 | ANTIMICROBIAL INKS AND SEALANTS | GROS ROBERT TIMOTHY (GB) | 2014-12-24 | — | — | WO | disclosed |
| WO-2012065610-A1 | METHOD AND SUBSTRATE WITH A QUAT COATING | VESTERGAARD FRANDSEN SA (CH) | 2012-05-24 | — | — | WO | disclosed |
| US-20100099738-A1 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-04-22 | — | — | US | disclosed |
| WO-2010030739-A1 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-03-18 | — | — | WO | disclosed |
| WO-2010030730-A1 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-03-18 | — | — | WO | disclosed |
| US-20100063135-A1 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-03-11 | — | — | US | disclosed |
| EP-1061922-B9 | USE OF N-SUBSTITUTED-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL COMPOUNDS FOR TREATING HEPATITIS VIRUS INFECTIONS | UNITED THERAPEUTICS CORP (US) | 2007-03-07 | — | — | EP | disclosed |
| EP-1061922-B1 | USE OF N-SUBSTITUTED-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL COMPOUNDS FOR TREATING HEPATITIS VIRUS INFECTIONS | SEARLE LLC (US) | 2006-06-28 | — | — | EP | disclosed |
| EP-0141593-A2 | Shampoo compositions | THE PROCTER & GAMBLE COMPANY (US) | 1985-05-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099738-A1 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF | LIPA, LIPG, LIPC | TSHR 1020/4885ALDH1A1 1734/4885THRB 1606/4885 |
| US-20100063135-A1 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF | LIPA, LIPG, LIPC | TSHR 1020/4885ALDH1A1 1734/4885THRB 1606/4885 |
| US-20190021998-A1 | TOPICAL NANOEMULSION THERAPY FOR WOUNDS | CUTA, MMP8, DSG1 | TSHR 4850/4885ALDH1A1 2106/4885THRB 4831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.